Let's focus on what we can do!

Facebook Twitter Instagram Linkedin
What are you looking for?

By Disabled People for Disabled People

  • Home
  • >
  • Ataxia
  • >
  • Agilis Biotherapeutics and Waisman Biomanufacturing Enter Into Exclusive Manufacturing Agreement for Friedreich’s … – Business Wire (press release)

Agilis Biotherapeutics and Waisman Biomanufacturing Enter Into Exclusive Manufacturing Agreement for Friedreich’s … – Business Wire (press release)

Friday, 19 February, 2016

Categories

Agilis Biotherapeutics and Waisman Biomanufacturing Enter Into Exclusive Manufacturing Agreement for Friedreich’s … – Business Wire (press release)

It is the most common inherited ataxia, with 1 in every 100 people being carriers of a mutated FXN gene. FA typically arises between the ages of 5 and 15 and manifests as difficulty with balance and coordination. Over time, the disease progresses to an ...

Read More

Source:Agilis Biotherapeutics and Waisman Biomanufacturing Enter Into Exclusive Manufacturing Agreement for Friedreich's ... - Business Wire (press release)

Categories :
  • Ataxia , 
  • Latest Headlines , 
  • Uncategorized
Socials :

Recent posts

@abilitytoday
Let's share our
memories
@abilitytodayuk
Let's be
friends
@abilitytoday
Let's chat and hear
your voice
@ability-today
Let's get down to
Business
Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Disability confident Logo
Donate to Ability Today CIC
(A Social Enterprise)

Copyright © 2023 All rights reserved

Facebook Twitter Instagram Linkedin